Levin Capital Strategies’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-70,613
Closed -$607K 253
2023
Q3
$607K Buy
70,613
+23,000
+48% +$163K 0.07% 119
2023
Q2
$376K Buy
47,613
+17,000
+56% +$118K 0.04% 151
2023
Q1
$228K Sell
30,613
-4,387
-13% -$43.6K 0.03% 185
2022
Q4
$413K Buy
35,000
+19,000
+119% +$217K 0.06% 139
2022
Q3
$148K Buy
16,000
+11,000
+220% +$133K 0.02% 191
2022
Q2
$49K Buy
+5,000
New +$101K 0.01% 243

Other funds holding ASPN

Levin Capital Strategies's ASPN Position: Q4 2023 in Review

Levin Capital Strategies sold out of Aspen Aerogels (ASPN) in Q4 2023, closing a stake of 70,613 shares — an estimated $607K sold.

Levin Capital Strategies first reported a position in ASPN in Q2 2022 and held it in 6 quarters. The position peaked at $607K in Q3 2023. 170 funds tracked by Wall St. Rank hold ASPN as of Q4 2023.

  • Levin Capital Strategies reported no remaining Aspen Aerogels position as of Q4 2023 after selling out during the quarter.
  • Levin Capital Strategies sold 70,613 Aspen Aerogels shares in Q4 2023, an estimated $607K.
  • Levin Capital Strategies first reported a position in Aspen Aerogels in Q2 2022 and held it in 6 quarters.
  • Levin Capital Strategies's Aspen Aerogels position peaked at $607K in Q3 2023.
  • 170 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2023.

Based on Levin Capital Strategies's 13F filing for Q4 2023, filed 6 Feb 2024.